Biotech

All Articles

Navigator brings up $100M to cultivate new autoimmune pipeline

.Sat nav Medicines has equipped on its own along with $one hundred million in collection A funds as ...

Duality looks for money for ADC tests as IPO wave infects Asia

.China's Duality Biotherapeutics has submitted (PDF) documentation for a Hong Kong IPO, seeking a co...

YolTech sells China liberties to gene editing and enhancing treatment for $29M

.Four months after Mandarin genetics editing company YolTech Therapies took its own cholesterol dise...

Addex inventory increases after Indivior offers up to $300M for compound

.Indivior is picking up a tiny molecule allosteric modulator made to treat drug use problem from Add...

Molecular Partners modifies AML trial over 'suboptimal exposure'

.Molecular Partners has pinpointed "suboptimal direct exposure" to its tetra-specific T-cell engager...

Despite blended market, a venture capital resurgence might be being available in Europe: PitchBook

.While the biotech financial investment performance in Europe has actually reduced somewhat complyin...

8 months after a $213M fundraise, genetics editor Volume makes decreases

.After rearing $213 million in 2023-- some of the year's biggest exclusive biotech shots-- Tome Bios...

BioMarin builds officer staff along with biotech vets-- Chutes &amp Ladders

.Welcome to today's Chutes &amp Ladders, our summary of notable leadership hirings, firings and also...

Biopharma Q2 VC struck highest degree considering that '22, while M&ampA reduced

.Venture capital financing right into biopharma rose to $9.2 billion throughout 215 deals in the 2nd...

Bicara, Zenas seek IPOs to press late-phase resources toward market

.Bicara Therapies and also Zenas Biopharma have actually provided clean motivation to the IPO market...